Tridec Services Inc

Burleson Research Technologies, Inc. is a renowned provider of immunotoxicology testing services catering to various industries including biotech, pharmaceutical, chemical manufacturing, and healthcare. The company's expertise lies in delivering high-quality testing services to ensure the safety and efficacy of products within these sectors. Generated from their website's infomation

BTI Targetry LLC is a leading provider of radionuclide production solutions, specializing in water and gas solid targets for PETtrace RDS-111, RDS-112, and CF1000-A MINItrace systems. With a team of experienced scientists, they offer a wide range of services and products, including 211At solid targets and 11C gas targets, supported by a comprehensive list of publications. Driven by a commitment to excellence, BTI Targetry LLC is dedicated to delivering high-quality visualization targets and reliable radionuclide production solutions. Their team, led by founding partner Bruce Wieland, PhD, and managing partner Matthew H. Stokely, PhD, is focused on meeting the unique needs of their clients in the field of radiopharmaceutical research and development.Generated from the website

BioCryst Pharmaceuticals designs, optimizes and develops novel small-molecule drugs that treat cancer, cardiovascular and autoimmune diseases and viral infections. BioCryst uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry and computer modeling. In structure-based drug design, scientists use detailed knowledge of the active sites of protein targets associated with particular diseases to design synthetic compounds that fight the disease. Structure-based drug design aims to create a molecule that will bind to the active site of a targeted enzyme, thereby preventing the normal chemical reaction and ultimately halting the progression of the disease. BioCryst was founded in 1986. The Company's stock is traded on the NASDAQ exchange under the symbol BCRX.